Literature DB >> 8291222

Immunohistochemical profile of invasive lobular carcinoma of the breast: predominantly vimentin and p53 protein negative, cathepsin D and oestrogen receptor positive.

W Domagala1, M Markiewski, R Kubiak, J Bartkowiak, M Osborn.   

Abstract

Vimentin, p53 protein and cathepsin D positivity were assessed by immunohistochemistry, and oestrogen receptor (ER) by an enzyme immunoassay, in invasive lobular carcinomas (LC) of the breast. While vimentin was positive in only 5% (3/57) and p53 protein was positive only in 3% (2/63), cathepsin D was expressed in 86% (48/56) and ER in 78% (25/32). Classical LC were negative for p53 protein and all except one were cathepsin D positive. These results are in contrast to invasive ductal breast carcinomas (DC), where the reported average incidence of vimentin and p53 protein is much higher (19% and 33% respectively) and that of cathepsin D and ER lower (63% and 67% respectively). Thus lack of expression of vimentin and lack of p53 positivity together with high incidence of expression of cathepsin D and ER are more often associated with lobular than with ductal differentiation of invasive breast cancer. The results show that LC, distinguished morphologically, can further be defined by its immunohistochemical profile. This in turn may point to underlying biological differences between LC and DC.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8291222     DOI: 10.1007/BF01606541

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  35 in total

1.  Infiltrating lobular carcinoma of the breast: response to endocrine therapy and survival.

Authors:  D B Smith; A Howell; J Wagstaff
Journal:  Eur J Cancer Clin Oncol       Date:  1987-07

2.  An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions.

Authors:  S R Wellings; H M Jensen; R G Marcum
Journal:  J Natl Cancer Inst       Date:  1975-08       Impact factor: 13.506

3.  The demonstration of alpha lactalbumin in human breast carcinomas.

Authors:  R A Walker
Journal:  J Pathol       Date:  1979-09       Impact factor: 7.996

4.  An immunocytochemical study of alpha-lactalbumin in human breast tissue.

Authors:  A J Bailey; J P Sloane; B S Trickey; M G Ormerod
Journal:  J Pathol       Date:  1982-05       Impact factor: 7.996

5.  Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients.

Authors:  J Isola; T Visakorpi; K Holli; O P Kallioniemi
Journal:  J Natl Cancer Inst       Date:  1992-07-15       Impact factor: 13.506

6.  Correlation of estrogen and progesterone receptors with histologic differentiation in mammary carcinoma.

Authors:  K S McCarty; T K Barton; B F Fetter; B H Woodard; J A Mossler; W Reeves; J Daly; W E Wilkinson; K S McCarty
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

7.  Histopathological characteristics and oestrogen receptor content in primary breast carcinoma.

Authors:  B B Rasmussen; C Rose; S M Thorpe; K Hou-Jensen; J L Daehnfeldt; T Palshof
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

8.  Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers.

Authors:  A D Thor; I I Moore DH; S M Edgerton; E S Kawasaki; E Reihsaus; H T Lynch; J N Marcus; L Schwartz; L C Chen; B H Mayall
Journal:  J Natl Cancer Inst       Date:  1992-06-03       Impact factor: 13.506

9.  Estrogen and progesterone receptors in breast carcinoma: correlations with epidemiology and pathology.

Authors:  M L Lesser; P P Rosen; R T Senie; K Duthie; C Menendez-Botet; M K Schwartz
Journal:  Cancer       Date:  1981-07-15       Impact factor: 6.860

Review 10.  Cathepsin D in breast cancer: from molecular and cellular biology to clinical applications.

Authors:  H Rochefort; F Capony; M Garcia
Journal:  Cancer Cells       Date:  1990-12
View more
  11 in total

1.  Loss of heterozygosity in lobular carcinoma in situ of the breast.

Authors:  S R Lakhani; N Collins; J P Sloane; M R Stratton
Journal:  Clin Mol Pathol       Date:  1995-04

2.  Biologic characteristics of premalignant breast disease.

Authors:  Kimberly Cole; Maria Tabernero; Karen S Anderson
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

3.  Prognostic factors in primary breast carcinoma.

Authors:  S E Pinder; I O Ellis; C W Elston
Journal:  J Clin Pathol       Date:  1995-11       Impact factor: 3.411

4.  Clinical and biological implications of the tumor microenvironment.

Authors:  David Tarin
Journal:  Cancer Microenviron       Date:  2012-08

5.  p53 gene mutations and expression of p53 and mdm2 proteins in invasive breast carcinoma. A comparative analysis with clinico-pathological factors.

Authors:  T Günther; R Schneider-Stock; J Rys; A Niezabitowski; A Roessner
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

6.  Prognostic value of cathepsin D in breast cancer: comparison of immunohistochemical and immunoradiometric detection methods.

Authors:  U J Göhring; A Scharl; U Thelen; A Ahr; G Crombach; B R Titius
Journal:  J Clin Pathol       Date:  1996-01       Impact factor: 3.411

Review 7.  Biological features of premalignant disease in the human breast.

Authors:  D C Allred; S K Mohsin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

8.  A component of lobular carcinoma in clinically lymph node-negative patients predicts for an increased likelihood of upstaging to pathologic stage III breast cancer.

Authors:  Renae D Van Wyhe; Abigail S Caudle; Simona F Shaitelman; George H Perkins; Thomas A Buchholz; Karen E Hoffman; Eric A Strom; Benjamin D Smith; Welela Tereffe; Wendy A Woodward; Michael C Stauder
Journal:  Adv Radiat Oncol       Date:  2018-02-26

9.  Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators.

Authors:  M A Levesque; G M Clark; H Yu; E P Diamandis
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

10.  Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome.

Authors:  Grazia Arpino; Valerie J Bardou; Gary M Clark; Richard M Elledge
Journal:  Breast Cancer Res       Date:  2004-02-17       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.